Orchestra BioMed Holdings, Inc. Excess Stock, Shares Outstanding
Orchestra BioMed Holdings, Inc. (OBIO) had Excess Stock, Shares Outstanding of 11.21 million shares as of 2022-12-31, per its 10-K filed 2023-01-25.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Excess Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesOutstanding · last filed 2023-01-25
- 2022-12-31: Excess Stock, Shares Outstanding 11.21M shares.
- 2022-09-30: Excess Stock, Shares Outstanding 11.21M shares.
- 2022-06-30: Excess Stock, Shares Outstanding 20.45M shares.
- 2022-03-31: Excess Stock, Shares Outstanding 20.45M shares.
| Period end | Excess Stock, Shares Outstanding |
|---|---|
| 2022-12-31 | 11.21M shares 10-K · filed 2023-01-25 |
| 2022-09-30 | 11.21M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 20.45M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 20.45M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 20.45M shares 10-K · filed 2023-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |